Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
JCI Insight|September 22, 2020
Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signalingZhiguo Chen, Stephen Li, Juan Mo, et al.
Plos One|October 1, 2011
Erk1 positively regulates osteoclast differentiation and bone resorptive activityYongzheng He, Karl Staser, Steven D Rhodes, et al.
The Journal of Biological Chemistry|February 25, 2012
Human anti-prion antibodies block prion peptide fibril formation and neurotoxicityXing Wei, Yvonne Roettger, Bailin Tan, et al.
Plos One|November 13, 2012
c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functionsYongzheng He, Steven D Rhodes, Shi Chen, et al.
Bone|March 29, 2011
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine modelWei Zhang, Steven D Rhodes, Liming Zhao, et al.
Stem Cells (Dayton, Ohio)|November 22, 2008
IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal ratsXing Wei, Zhimei Du, Liming Zhao, et al.
Human Molecular Genetics|May 16, 2019
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformationSteven D Rhodes, Yongzheng He, Abbi Smith, et al.
The Journal of Biological Chemistry|June 27, 2006
Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growthHanying Chen, Weidong Yong, Shuxun Ren, et al.
Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Oncotarget|February 9, 2018
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2Benjamin M Wahle, Eric T Hawley, Yongzheng He, et al.
Pageof 4